🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 28/11/1977 | 0,0113 USD |
| 29/08/1977 | 0,0099 USD |
| 31/05/1977 | 0,0099 USD |
| 01/03/1977 | 0,0099 USD |
| 30/11/1976 | 0,0099 USD |
| 30/08/1976 | 0,0093 USD |
| 01/06/1976 | 0,0093 USD |
| 02/03/1976 | 0,0093 USD |
| 01/12/1975 | 0,0093 USD |
| 29/08/1975 | 0,0093 USD |
| 02/06/1975 | 0,0093 USD |
| 03/03/1975 | 0,0093 USD |
| 30/08/1974 | 0,0093 USD |
| 03/06/1974 | 0,0093 USD |
| 04/03/1974 | 0,0093 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/12/2009 | 36,06 | 36,24 | 35,83 | 36,02 | +0,16% | 1,14% | 14.771.350 |
| 21/12/2009 | 35,76 | 36,66 | 35,75 | 35,96 | +0,78% | 2,53% | 15.497.090 |
| 18/12/2009 | 35,65 | 36,06 | 35,50 | 35,69 | +0,32% | 1,58% | 26.643.618 |
| 17/12/2009 | 36,02 | 36,12 | 35,55 | 35,57 | -1,25% | 1,56% | 19.433.483 |
| 16/12/2009 | 36,28 | 36,36 | 35,80 | 36,02 | -0,66% | 1,53% | 17.476.238 |
| 15/12/2009 | 35,94 | 36,26 | 35,56 | 36,26 | +0,61% | 1,94% | 13.495.096 |
| 14/12/2009 | 35,56 | 36,07 | 35,56 | 36,04 | +1,89% | 1,42% | 12.981.262 |
| 11/12/2009 | 35,67 | 35,67 | 35,18 | 35,37 | -1,25% | 1,36% | 14.402.769 |
| 10/12/2009 | 35,70 | 36,18 | 35,68 | 35,82 | +1,05% | 1,42% | 15.336.642 |
| 09/12/2009 | 34,64 | 35,52 | 34,45 | 35,45 | +2,20% | 3,11% | 18.611.537 |
| 08/12/2009 | 34,97 | 35,30 | 34,60 | 34,69 | -0,95% | 1,99% | 16.286.234 |
| 07/12/2009 | 34,85 | 35,34 | 34,81 | 35,02 | +0,00% | 1,53% | 10.448.036 |
| 04/12/2009 | 35,51 | 35,78 | 34,96 | 35,02 | -0,19% | 2,31% | 17.412.415 |
| 03/12/2009 | 35,03 | 35,34 | 34,88 | 35,09 | -0,08% | 1,33% | 13.639.406 |
| 02/12/2009 | 34,83 | 35,31 | 34,78 | 35,11 | -0,22% | 1,51% | 12.601.990 |
| 01/12/2009 | 34,63 | 35,52 | 34,63 | 35,19 | +1,85% | 2,59% | 17.421.533 |
| 30/11/2009 | 34,50 | 34,67 | 34,23 | 34,55 | -0,22% | 1,27% | 19.246.834 |
| 27/11/2009 | 34,33 | 34,87 | 33,99 | 34,63 | -0,77% | 2,56% | 9.402.551 |
| 25/11/2009 | 34,63 | 34,99 | 34,31 | 34,90 | +0,97% | 1,96% | 11.693.374 |
| 24/11/2009 | 34,62 | 35,14 | 34,22 | 34,56 | -0,55% | 2,67% | 22.260.673 |
| 23/11/2009 | 35,07 | 35,27 | 34,53 | 34,75 | -0,11% | 2,10% | 23.842.629 |
| 20/11/2009 | 33,83 | 34,99 | 33,71 | 34,79 | +3,20% | 3,78% | 38.112.721 |
| 19/11/2009 | 33,48 | 34,08 | 33,17 | 33,71 | +0,54% | 2,74% | 25.142.358 |
| 18/11/2009 | 32,70 | 33,78 | 32,52 | 33,53 | +2,48% | 3,85% | 29.544.482 |
| 17/11/2009 | 32,25 | 32,73 | 31,82 | 32,72 | +1,42% | 2,81% | 17.354.985 |
| 16/11/2009 | 32,42 | 32,78 | 31,98 | 32,26 | +2,15% | 2,44% | 26.302.180 |
| 13/11/2009 | 31,77 | 31,97 | 31,49 | 31,58 | +0,36% | 1,50% | 15.211.930 |
| 12/11/2009 | 31,53 | 31,94 | 31,36 | 31,47 | -0,72% | 1,85% | 14.775.542 |
| 11/11/2009 | 32,19 | 32,20 | 31,60 | 31,70 | -1,16% | 1,87% | 18.316.210 |
| 10/11/2009 | 31,98 | 32,19 | 31,80 | 32,07 | +0,54% | 1,22% | 16.626.520 |